COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,944 Articles (22,604 medRxiv, 8,340 bioRxiv)

Most recent first Previous |  Page 1137: Articles 11361-11370  | Next

Geographic Disparities and Predictors of COVID-19 Hospitalization Risk in the St. Louis Area, Missouri (USA).
Igoe, M. E., Das, P., Lenhart, S., Lloyd, A., Luong, L., Tian, D., Lanzas, C., Odoi, A.
10.1101/2021.10.21.21265289 — Posted: 2021-10-25
The impact of vaccinating adolescents and children on COVID-19 disease outcomes
Ainslie, K. E. C., Backer, J. A., de Boer, P., van Hoek, A. J., Klinkenberg, D., Korthals Altes, H., Leung, K. Y., de Melker, H., Miura, F., Wallinga, J.
10.1101/2021.10.21.21265318 — Posted: 2021-10-25
Comparative Effectiveness of BNT162b2 versus Ad26.COV2.S for the Prevention of COVID-19 among Dialysis Patients
Brunelli, S. M., Sibbel, S., Karpinski, S., Marlowe, G., Walker, A. G., Giullian, J., Van Wyck, D., Kelley, T., Lazar, R., Zywno, M. L., Connaire, J. J., Young, A., Tentori, F.
10.1101/2021.10.21.21265339 — Posted: 2021-10-25
Factors affecting nurses' duty to care during the COVID-19 pandemic
shin, h., Kim, K. h., Kim, J.-s., Kwak, Y.-h.
10.1101/2021.10.21.21265272 — Posted: 2021-10-25
SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19
Martinez-Colon, G. J., Ratnasiri, K., Chen, H., Jiang, S., Zanley, E., Rustagi, A., Verma, R., Chen, H., Andrews, J. R., Mertz, K., Tzankov, A., Azagury, D., Boyd, J., Nolan, G. P., Schürch, C. M., Matter, M. S., Blish, C. A., McLaughlin, T. L.
10.1101/2021.10.24.465626 — Posted: 2021-10-25
SARS-CoV-2 Infection Impacts Carbon Metabolism and Depends on Glutamine for Replication in Syrian Hamster Astrocytes
Oliveira, L. G., Angelo, Y. d. S., Yamamoto, P., Carregari, V. C., Crunfli, F., Reis-de-Oliveira, G., Costa, L., Duque, E. A., Santos, N. B., Almeida, G. M., Firmino, E. M. S., Paiva, I. M., Polonio, C. M., Zanluqui, N. G., Oliveira, M. G., Davanzo, G. G., Ayupe, M. C., Salgado, C. L., Campos, A. C. A., Goes, L. G. B., Cunha, M. P., Lima, M. R. D., Fonseca, D. M., Guimaraes, A. M. S., Minoprio, P. M., Munhoz, C. D., Mori, C. M. C., Moraes-Vieira, P. M., Cunha, T. M., Martins-de-Souza, D., Peron, J. P. S.
10.1101/2021.10.23.465567 — Posted: 2021-10-24 Discussion: Offsite
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
Gagne, M., Corbett, K. S., Flynn, B. J., Foulds, K. E., Wagner, D. A., Andrew, S. F., Todd, J.-P. M., Honeycutt, C. C., McCormick, L., Nurmukhambetova, S. T., Davis-Gardner, M. E., Pessaint, L., Bock, K. W., Nagata, B. M., Minai, M., Werner, A. P., Moliva, J. I., Tucker, C., Lorang, C. G., Zhao, B., McCarthy, E., Cook, A., Dodson, A., Mudvari, P., Roberts-Torres, J., Laboune, F., Wang, L., Goode, A., Kar, S., Boyoglu-Barnum, S., Yang, E. S., Shi, W., Ploquin, A., Doria-Rose, N., Carfi, A., Mascola, J. R., Boritz, E. A., Edwards, D. K., Andersen, H., Lewis, M. G., Suthar, M. S., Graham, B. S., Roederer, M., Moore, I. N., Nason, M. C., Sullivan, N. J., Douek, D. C., Seder, R. A.
10.1101/2021.10.23.465542 — Posted: 2021-10-24
The humanized nanobody RBD-1-2G tolerates the spike N501Y mutation to neutralize SARS-CoV-2
Fu, Y., da Fonseca Rezende e Mello, J., Fleming, B. D., Renn, A., Chen, C. Z., Hu, X., Xu, M., Gorshkov, K., Hanson, Q., Zheng, W., Lee, E. M., Perera, L., Petrovich, R., Pradhan, M., Eastman, R. T., Itkin, Z., Stanley, T., Hsu, A., Dandey, V., Gillette, W., Taylor, T., Ramakrishnan, N., Perkins, S., Esposito, D., Oh, E., Susumu, K., Wolak, M., Ferrer, M., Hall, M. D., Borgnia, M. J., Simeonov, A.
10.1101/2021.10.22.465476 — Posted: 2021-10-24
Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
Iaconis, D., Talarico, C., Manelfi, C., Cesta, M. C., Zippoli, M., Caccuri, F., Matusali, G., Bordi, L., Scorzolini, L., Bucci, E. M., Caruso, A., Nicastri, E., Allegretti, M., Beccari, A. R.
10.1101/2021.10.22.465294 — Posted: 2021-10-24
Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies
Eddins, D. J., Bassit, L. C., Chandler, J., Haddad, N. S., Musall, K., Yang, J., Kosters, A., Dobosh, B. S., Hernandez, M. R., Ramonell, R. P., Tirouvanziam, R. M., Lee, F. E.-H., Zandi, K., Schinazi, R. F., Ghosn, E.
10.1101/2021.10.22.465481 — Posted: 2021-10-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).